Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients

Clinical trial NCT03879876 · COMPLETED

Trial details

NCT number: NCT03879876
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pediatric Patients Any Type of Severe Combined Immunodeficiency (SCID)Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Start date: 2020-05-13
Primary completion: 2023-09-03
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.